Bruker Q2 2024 Earnings Report
Key Takeaways
Bruker reported strong Q2 2024 results with revenues of $800.7 million, up 17.4% year-over-year, and organic revenue growth of 7.4%. The company's non-GAAP EPS increased by 4.0% to $0.52. Bruker has increased its full-year revenue guidance to $3.38-$3.44 billion, which now includes the NanoString business.
Q2 2024 revenues reached $800.7 million, a 17.4% increase year-over-year.
Organic revenue grew by 7.4% year-over-year.
GAAP EPS was $0.05, while non-GAAP EPS was $0.52, up 4.0% year-over-year.
Full-year 2024 revenue guidance increased to $3.38-$3.44 billion, including the NanoString business.
Bruker
Bruker
Forward Guidance
Bruker now expects FY 2024 revenues of $3.38 to $3.44 billion, with 14% to 16% year-over-year reported revenue growth. Bruker now expects FY 2024 non-GAAP EPS of $2.59 to $2.64.
Positive Outlook
- Organic revenue growth of 5% to 7%.
- M&A tailwind of approximately 10%.
- CER revenue growth of 15% to 17%.
- Revenue between $3.38 to $3.44 billion
- Non-GAAP EPS of $2.59 to $2.64
Challenges Ahead
- A foreign currency translation revenue headwind of approximately -1%.
- Impact of supply chain challenges, including inflationary pressures
- Impact of geopolitical tensions and any sanctions
- Conflict in Israel, Palestine and surrounding areas
- Ongoing tensions between the United States and China